PNC Financial Services Group
PCVX icon

PNC Financial Services Group’s Vaxcyte PCVX Stock Holding History

PNC Financial Services Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$781K Buy
13,728
+1,928
+16% +$112K ﹤0.01% 1546
2026
Q2 		$686K Sell
11,800
-3,156
-21% -$171K ﹤0.01% 1590
2026
Q1 		$869K Buy
14,956
+39
+0.3% +$2.12K ﹤0.01% 1359
2025
Q4 		$688K Buy
14,917
+514
+4% +$23K ﹤0.01% 1453
2025
Q3 		$519K Buy
14,403
+3,184
+28% +$105K ﹤0.01% 1612
2025
Q2 		$365K Buy
11,219
+1,619
+17% +$53.1K ﹤0.01% 1782
2025
Q1 		$362K Buy
9,600
+524
+6% +$41.9K ﹤0.01% 1757
2024
Q4 		$743K Buy
9,076
+1,397
+18% +$139K ﹤0.01% 1300
2024
Q3 		$877K Sell
7,679
-765
-9% -$68.9K ﹤0.01% 1232
2024
Q2 		$638K Buy
8,444
+1,080
+15% +$73.5K ﹤0.01% 1362
2024
Q1 		$503K Buy
7,364
+378
+5% +$26.2K ﹤0.01% 1531
2023
Q4 		$439K Buy
6,986
+1,411
+25% +$73.3K ﹤0.01% 1605
2023
Q3 		$284K Buy
5,575
+5,119
+1,123% +$253K ﹤0.01% 1869
2023
Q2 		$22.8K Buy
456
+339
+290% +$16.1K ﹤0.01% 3493
2023
Q1 		$4.39K Sell
117
-6
-5% -$255 ﹤0.01% 4083
2022
Q4 		$5.9K Buy
123
+23
+23% +$903 ﹤0.01% 3941
2022
Q3 		$2K Sell
100
-6
-6% -$152 ﹤0.01% 4201
2022
Q2 		$2K Buy
+106
New +$2.45K ﹤0.01% 4230

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor San Francisco, California $252M AUM 45.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

PNC Financial Services Group's PCVX Position: Q3 2026 in Review

PNC Financial Services Group increased its Vaxcyte (PCVX) stake by 16% in Q3 2026, buying an estimated $112K and bringing the position to 13,728 shares worth $781K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

PNC Financial Services Group first reported a position in PCVX in Q2 2022 and has held it in 18 quarters since. The position peaked at $877K in Q3 2024. 259 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • PNC Financial Services Group held 13,728 shares of Vaxcyte worth $781K as of Q3 2026.
  • PNC Financial Services Group bought 1,928 Vaxcyte shares in Q3 2026, an estimated $112K.
  • Vaxcyte made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1546 holding.
  • PNC Financial Services Group first reported a position in Vaxcyte in Q2 2022 and has held it in 18 quarters since.
  • PNC Financial Services Group's Vaxcyte position peaked at $877K in Q3 2024.
  • 259 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.